Weil Company’s Forte Biosciences FBRX Stock Holding History

Weil Company’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-24,765	Closed	-$526K	–	135
2026 Q2	$526K	Hold	24,765	–	–	0.09%	88
2026 Q1	$641K	Buy	+24,765	New	+$713K	0.14%	76

Weil Company's FBRX Position: Q3 2026 in Review

Weil Company sold out of Forte Biosciences (FBRX) in Q3 2026, closing a stake of 24,765 shares — an estimated $526K sold.

Weil Company first reported a position in FBRX in Q1 2026 and held it in 2 quarters. The position peaked at $641K in Q1 2026. 0 funds tracked by Wall St. Rank hold FBRX as of Q3 2026.

Weil Company reported no remaining Forte Biosciences position as of Q3 2026 after selling out during the quarter.
Weil Company sold 24,765 Forte Biosciences shares in Q3 2026, an estimated $526K.
Weil Company first reported a position in Forte Biosciences in Q1 2026 and held it in 2 quarters.
Weil Company's Forte Biosciences position peaked at $641K in Q1 2026.
0 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2026.

Based on Weil Company's 13F filing for Q3 2026, filed 14 Oct 2026.